Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 131-137

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 – 2012

By Dymock Brian W   See Cheng Shang  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 449-501

Informa Healthcare

Access to resources Recommend Favorite

IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3042-3047

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1767-1784

Bentham Science Publishers

Access to resources Recommend Favorite

Imatinib: Emergence of JAK2V617F clone leading to polycythaemia vera, in an elderly patient?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite